NCT04308330 2023-10-26
NYMC195
New York Medical College
Phase 1 Unknown
Clinical Trials
5 trialsNCT01879085 2022-09-21
GemTax
University of Pittsburgh
Phase 1/2 Completed
NCT01294670 2021-11-18
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT01110876 2021-08-25
Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT00918489 2018-10-17
SAHA-I
Heidelberg University
Phase 2 Completed